Zhongke Huarui is a regenerative medicine service provider, focusing on the research, application and promotion of regenerative medicine stem cell exosome technology, and clinical transformation and application of biological basic research and regenerative medicine innovative research, committed to providing users with Provide relevant health management solutions. Recently, Zhongke Huarui was acquired by Suning Global.
This article is reprinted from: https://www.itjuzi.com/merger/9098
This site is for inclusion only, and the copyright belongs to the original author.